Translator Disclaimer
1 June 2014 PHARMACOKINETICS OF CEFOVECIN (CONVENIA®) IN WHITE BAMBOO SHARKS (CHILOSCYLLIUM PLAGIOSUM) AND ATLANTIC HORSESHOE CRABS (LIMULUS POLYPHEMUS)
Author Affiliations +
Abstract

Cefovecin was administered to six healthy adult white bamboo sharks (Chiloscyllium plagiosum) and six healthy adult Atlantic horseshoe crabs (Limulus polyphemus) to determine its pharmacokinetics in these species. A single dose of cefovecin at 8 mg/kg was administered subcutaneously in the epaxial region of the bamboo sharks and in the proximal articulation of the lateral leg of the horseshoe crabs. Blood and hemolymph samples were collected at various time points from bamboo sharks and Atlantic horseshoe crabs. High performance liquid chromatography was performed to determine plasma levels of cefovecin. The terminal half-life of cefovecin in Atlantic horseshoe crabs was 37.70 ± 9.04 hr and in white bamboo sharks was 2.02 ± 4.62 hr. Cefovecin concentrations were detected for 4 days in white bamboo sharks and for 14 days in Atlantic horseshoe crabs. No adverse effects associated with cefovecin administration were seen in either species.

American Association of Zoo Veterinarians
James C. Steeil, Juergen Schumacher, Robert H. George, Frank Bulman, Katherine Baine, and Sherry Cox "PHARMACOKINETICS OF CEFOVECIN (CONVENIA®) IN WHITE BAMBOO SHARKS (CHILOSCYLLIUM PLAGIOSUM) AND ATLANTIC HORSESHOE CRABS (LIMULUS POLYPHEMUS)," Journal of Zoo and Wildlife Medicine 45(2), 389-392, (1 June 2014). https://doi.org/10.1638/2013-0061R2.1
Received: 2 April 2013; Published: 1 June 2014
JOURNAL ARTICLE
4 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top